AFRICA HEALTH ExCon

AFRICA HEALTH ExCon is Egypt’s leading international specialized medical exhibition and a highly influential annual healthcare event in North Africa. The show is designed to serve as a central platform for medical innovation and trade across Africa and the Middle East, bringing together government agencies and healthcare professionals from around the world. It places particular emphasis on fostering deep engagement between buyers and suppliers, thereby driving global medical trade and connectivity. Co-hosted by the Africa Centres for Disease Control and Prevention (Africa CDC) and endorsed by Egypt’s Unified Purchasing Authority (UPA), the exhibition is guided by the vision of “building a continental hub for medical innovation and trade in Africa,” opening a vital gateway for global healthcare stakeholders to access the African market.

The 4th AFRICA HEALTH ExCon was held from June 25 to 27, 2025, at the Egypt International Exhibition Center in Cairo, Egypt. 。 The exhibition welcomed over 380 companies from more than 100 countries and regions, attracted over 45,000 professional visitors, and featured 21 hands-on workshops, 428 academic seminars, and numerous specialized side events. It brought together global healthcare policymakers, industry leaders, and corporate representatives to advance medical innovation, foster trade connectivity, and promote the localization of the healthcare sector in Africa and the Middle East.

☆ Egypt spans the continents of Asia and Africa and faces Europe across the sea. Leveraging its unique geographical advantages and a well-developed transportation network, it can efficiently serve the Middle East, North Africa, and even Europe, making it a pivotal gateway for global medical device companies seeking to enter the African market.

☆ Egypt’s current population stands at 108 million, and is projected to grow to 130 million by 2030 and further increase to 175 million by 2050. This sustained population growth will directly drive a corresponding rise in overall demand within the healthcare sector.

☆   Egypt is the second-largest medical device market in the Middle East and North Africa, and serves as the core engine of the North African healthcare market. 。 In 2025, the Egyptian healthcare market is projected to be approximately USD 9 billion (based on Middle East regional accounting standards), with a compound annual growth rate of 9.8%, and is expected to exceed USD 14 billion by 2030.

☆ In 2025, the Egyptian government has designated healthcare as a core area of public welfare, providing substantial funding to the health sector: EGP 22 billion for pharmaceuticals, EGP 12.4 billion for raw materials, EGP 11 billion for medical supplies, EGP 2.8 billion for equipment maintenance, and EGP 5 billion for therapeutic drugs and infant formula. Additionally, EGP 15.1 billion has been allocated to deliver healthcare services to uninsured low-income citizens, while EGP 5.9 billion is earmarked for health insurance coverage for students, housewives, and children not covered by the comprehensive health insurance scheme.

☆ The public healthcare system encompasses institutions directly under the Ministry of Health, university‑affiliated facilities, and quasi‑public medical entities. These organizations typically operate on a large scale with ample bed capacity; among the 145 university hospitals nationwide, intensive care unit beds account for 50% of the total in the public sector. Their procurement systems are highly institutionalized and standardized, with tendering and centralized purchasing serving as core mechanisms. The Unified Procurement Authority (UPA) of Egypt acts as the sole procurement entity for the public sector, having completed centralized procurement totaling over EGP 22 billion for pharmaceuticals and EGP 11 billion for medical devices in 2025 alone.

☆ Private healthcare is the core growth engine of Egypt’s healthcare market, benefiting from the maturation of the national health insurance system, rising public health awareness, and supportive government policies. As a result, both the overall market size and its specialized segments are expanding: by 2025, private healthcare is expected to account for 50% of the market, up from 35% in 2019—a substantial leap; meanwhile, niche segments such as independent imaging centers, outpatient diagnostic laboratories, specialized clinics for cardiology, oncology, and pediatrics, chain‑based community clinics, and rehabilitation centers are rapidly gaining ground. As of January 2026, 537 healthcare facilities in Egypt have joined the national health insurance network, with private providers accounting for 31%—officially becoming a key provider of insured services. At the same time, leveraging its medical tourism assets, Egypt is partnering with international healthcare institutions to develop high‑end specialty centers for cancer treatment, heart transplantation, and other advanced services, attracting patients from the Middle East, Africa, and even Europe, thereby boosting medical service exports. By 2025, the medical tourism sector is projected to exceed US$2.5 billion, maintaining a compound annual growth rate of over 10%, with dentistry, ophthalmology, and cardiovascular care emerging as the most prominent categories.

☆ Under the “Digital Egypt 2025” national initiative, digital healthcare has emerged as the fastest-growing segment of Egypt’s healthcare market. By 2025, the size of Egypt’s digital health and health-tech sector is projected to reach approximately USD 600 million, with an annual growth rate of 26%, driven primarily by telemedicine, AI‑powered disease monitoring, and the digitalization of medical supply chains. In collaboration with the African Union Development Agency (AUDA‑NEPAD), Egypt is advancing an Africa‑wide AI‑healthcare strategy, prioritizing the deployment of AI in disease surveillance and the delivery of healthcare services; corresponding digital health solutions have become key procurement priorities for the government.

☆ Egypt relies on imports for 90% of its medical consumables, with Chinese products accounting for only 15–20%, far behind European and American brands. In the basic consumables segment—such as syringes, infusion sets, and standard dressings—Chinese manufacturers enjoy a clear cost‑performance advantage, aligning well with the centralized procurement needs of public hospitals and offering substantial room for substitution. Meanwhile, competition in niche areas like dialysis consumables, wound care, ostomy products, and rehabilitation supplies remains relatively mild, while demand continues to grow. At the same time, significant gaps persist in primary healthcare, creating an urgent need for basic consumables and providing Chinese companies with an opportunity to enter the market at a low barrier to entry.

☆ “As a specialized plan for the healthcare sector, ‘Healthy Egypt 2025’ serves as a key strategic foothold for enterprises to engage in areas that directly benefit people’s livelihoods. It builds on the medical‑industry cooperation under the Belt and Road Initiative and the health‑and‑wellness projects of the Forum on China–Africa Cooperation, driving the modernization of Egypt’s healthcare system and improving living standards. The initiative also aims to propel Egypt’s medical‑device manufacturing from its nascent stage—moving from “zero to one”—to large‑scale production, exemplified by Mindray’s joint ultrasound‑equipment plant with Egypt, which has enabled local mass production of high‑end medical devices and filled an important industrial gap. Furthermore, the two sides plan to advance joint manufacturing of dental equipment and medical consumables, gradually reducing Egypt’s reliance on medical devices imported from Western countries.

2025 Data:

More than 380 companies from over 100 countries and regions

45,000+ professional visitors

21 hands-on workshops will be held.

428 academic symposiums and numerous specialized side events

● Medical Devices and Instruments

● Hospital infrastructure and supplies

●Diagnosis and Laboratory

●Digital Healthcare and IT

●Disposable items and consumables

● Imaging and Diagnosis

●Emergency Medicine and Intensive Care

● Surgical equipment and instruments

● Rehabilitation and Orthopedics

● Pharmaceuticals, health supplements, and pharmaceutical raw materials

1. Complete the exhibition application form, ensuring that all information is accurate and error-free.

2. Confirm booth information, sign the exhibition contract, and pay the applicable fees as stipulated in the contract.

3. Handle matters related to booth registration, banner production, the official exhibition catalog, rental of exhibition equipment and booth construction, as well as exhibit transportation.

4. Prepare exhibition materials such as brochures, posters, and business cards.

5. Confirm the list of exhibitors and coordinate their exhibition schedules.

6. If a visa is required, promptly arrange the necessary visa procedures for all exhibition participants.

7. During the implementation phase, systematically advance all exhibition-related tasks to ensure the project is successfully launched and executed.

8. Upon completion of the project, arrange for the issuance of invoices.